Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cerebrospinal fluid proteomic profiling reflects biological heterogeneity of early-onset Alzheimer's disease dementia

ABSTRACT: Cerebrospinal fluid proteomic profiling reflects biological heterogeneity of early-onset Alzheimer's disease dementia from The First Affiliated Hospital of USTC

ORGANISM(S): Homo Sapiens

SUBMITTER: Qiqiang Tang

PROVIDER: PXD040216 | iProX | Thu Feb 16 00:00:00 GMT 2023

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid

Project description:Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid

| PRJNA555618 | ENA

Genetic Consortium for Late Onset Alzheimer's Disease 6K

Project description:Genetic Consortium for Late Onset Alzheimer's Disease 6K

| PRJNA75441 | ENA

Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [CSF]

Project description:Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [CSF]

| PRJNA557207 | ENA

Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA]

Project description:Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA]

| PRJNA555620 | ENA

CIDR_NIA Late Onset Alzheimer's Disease:Genome-Wide Association Study

Project description:CIDR_NIA Late Onset Alzheimer's Disease:Genome-Wide Association Study

| PRJNA75485 | ENA

Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TCR-seq]

Project description:Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TCR-seq]

| PRJNA557227 | ENA

Circulating microRNAs associated to cerebrospinal fluid amyloid-β and phosphorylated tau levels as potential non-invasive biomarkers for mild cognitive impairment and Alzheimer’s disease

Project description:To identify the potential biomarkers of Alzheimer's disease (AD) based on circulating microRNAs (miRNAs), we developed a new approach using feature selection and linear mixed model. The miRNA sequencing data of 105 plasma and 112 serum samples from 112 subjects including 28 AD cases, 63 mild cognitive impairment (MCI), and 21 controls were used to identify cerebrospinal fluid biomarkers associated miRNAs. The potential of these miRNAs as biomarkers of AD or MCI was researched and validated via both internal and external dataset. Patient classification was effectuated in compliance with the NIA-AA criteria for “MCI due to AD” and “Dementia due to AD”.

2024-02-26 | GSE215789 | GEO

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

Project description:Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming

| PRJNA1063270 | ENA

snRNAseq of humanized mouse model of late-onset Alzheimer's Disease

Project description:snRNAseq of humanized mouse model of late-onset Alzheimer's Disease

| PRJEB91430 | ENA

Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming II

Project description:Modeling late-onset Alzheimer's disease neuropathology via direct neuronal reprogramming II

| PRJNA1064158 | ENA